Strongyloidiasis in humans and dogs in Southern Italy : an observational study
© 2023. The Author(s)..
Strongyloidiasis is a clinical issue both in humans and in dogs. Moreover, there are concerns about its zoonotic potential. We aimed to explore Strongyloides stercoralis epidemiology in Southern Italy in humans and dogs sharing the same environment in three different settings: (1) kennels (group K); (2) livestock farms (group L) and (3) agricultural farms (group A). For humans, a commercial ELISA test was used for screening. RT-PCR on faecal samples was done for people testing positive or equivocal at serology. On dog's faecal samples, Baermann test and RT-PCR were performed. A total of 145 dogs and 139 persons were tested. Based on faecal tests in dogs and serology in humans, a S. stercoralis positivity of 4.1% and 6.5% was revealed, respectively. The sites where cases were found were different for animals and humans. In dogs the highest positivity was in group K (6.7% against 2% and 0% in L and A). Differently, in humans the proportion of positive results was similar between the groups (p = 0.883). Fifty percent (3/6) of positive dogs were healthy; the other dogs presented weight loss and/or diarrhoea. ELISA-positive persons (n=9) were all in health, but abdominal pain (37.5%), urticaria (22.2%) and asthma (22.2%) were reported, resolving after treatment with oral ivermectin 200 μg/kg. RT-PCR performed on 13 human faecal samples resulted negative. These findings suggest that strongyloidiasis is present in humans and dogs in Southern Italy, and screening in larger cohorts would be needed for more accurate estimates.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:122 |
---|---|
Enthalten in: |
Parasitology research - 122(2023), 12 vom: 21. Dez., Seite 2885-2890 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Paradies, Paola [VerfasserIn] |
---|
Links: |
---|
Themen: |
70288-86-7 |
---|
Anmerkungen: |
Date Completed 01.12.2023 Date Revised 01.12.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1007/s00436-023-07978-1 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM362318727 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM362318727 | ||
003 | DE-627 | ||
005 | 20231226091004.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s00436-023-07978-1 |2 doi | |
028 | 5 | 2 | |a pubmed24n1207.xml |
035 | |a (DE-627)NLM362318727 | ||
035 | |a (NLM)37735273 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Paradies, Paola |e verfasserin |4 aut | |
245 | 1 | 0 | |a Strongyloidiasis in humans and dogs in Southern Italy |b an observational study |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 01.12.2023 | ||
500 | |a Date Revised 01.12.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2023. The Author(s). | ||
520 | |a Strongyloidiasis is a clinical issue both in humans and in dogs. Moreover, there are concerns about its zoonotic potential. We aimed to explore Strongyloides stercoralis epidemiology in Southern Italy in humans and dogs sharing the same environment in three different settings: (1) kennels (group K); (2) livestock farms (group L) and (3) agricultural farms (group A). For humans, a commercial ELISA test was used for screening. RT-PCR on faecal samples was done for people testing positive or equivocal at serology. On dog's faecal samples, Baermann test and RT-PCR were performed. A total of 145 dogs and 139 persons were tested. Based on faecal tests in dogs and serology in humans, a S. stercoralis positivity of 4.1% and 6.5% was revealed, respectively. The sites where cases were found were different for animals and humans. In dogs the highest positivity was in group K (6.7% against 2% and 0% in L and A). Differently, in humans the proportion of positive results was similar between the groups (p = 0.883). Fifty percent (3/6) of positive dogs were healthy; the other dogs presented weight loss and/or diarrhoea. ELISA-positive persons (n=9) were all in health, but abdominal pain (37.5%), urticaria (22.2%) and asthma (22.2%) were reported, resolving after treatment with oral ivermectin 200 μg/kg. RT-PCR performed on 13 human faecal samples resulted negative. These findings suggest that strongyloidiasis is present in humans and dogs in Southern Italy, and screening in larger cohorts would be needed for more accurate estimates | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Observational Study | |
650 | 4 | |a Observational Study, Veterinary | |
650 | 4 | |a Dogs | |
650 | 4 | |a ELISA | |
650 | 4 | |a Humans | |
650 | 4 | |a RT-PCR | |
650 | 4 | |a Strongyloides stercoralis | |
650 | 7 | |a Ivermectin |2 NLM | |
650 | 7 | |a 70288-86-7 |2 NLM | |
700 | 1 | |a Digiaro, Serena |e verfasserin |4 aut | |
700 | 1 | |a Colella, Antonella |e verfasserin |4 aut | |
700 | 1 | |a Greco, Beatrice |e verfasserin |4 aut | |
700 | 1 | |a Recchia, Alessandra |e verfasserin |4 aut | |
700 | 1 | |a Prato, Marco Giuseppe |e verfasserin |4 aut | |
700 | 1 | |a Mazzi, Cristina |e verfasserin |4 aut | |
700 | 1 | |a Losurdo, Giuseppe |e verfasserin |4 aut | |
700 | 1 | |a Di Leo, Alfredo |e verfasserin |4 aut | |
700 | 1 | |a Formenti, Fabio |e verfasserin |4 aut | |
700 | 1 | |a Buonfrate, Dora |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Parasitology research |d 1988 |g 122(2023), 12 vom: 21. Dez., Seite 2885-2890 |w (DE-627)NLM012981532 |x 1432-1955 |7 nnns |
773 | 1 | 8 | |g volume:122 |g year:2023 |g number:12 |g day:21 |g month:12 |g pages:2885-2890 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00436-023-07978-1 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 122 |j 2023 |e 12 |b 21 |c 12 |h 2885-2890 |